Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Group Diabetes Control and Complications Research.
Effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus.
N Eng J Med, 329 (1993), pp. 977-986
[3.]
K. Dahl-Jorgensen.
Modern insulin therapy in children and adolescents.
Acta Paediatr Suppl, 427 (1999), pp. 25-30
[4.]
F. Holleman, J.B.L. Hoekstra.
Insulin Lispro.
N Engl J Med, 337 (1997), pp. 176-183
[5.]
D.C. Howey, R.R. Bowsher, R.L. Brunelle, J.R. Woodworth.
Lys(b28), Pro (B29)-human insulin: a rapidly absorbed analogue of human insulin.
Diabetes, 43 (1994), pp. 396-402
[6.]
E. Torlone, C. Fanelli, A.M. Rambotti, G. Kassi, F. Modarelli, A. DiVinceno, et al.
Pharmacockinetics, pharmacodynamics and glucose counter regulation following subcutaneus injection of the monomeric insulin analog Lys (B28), Pro (B29) in IDDM.
Diabetologia, 37 (1994), pp. 713-720
[7.]
M.J. Tuset, I. Martínez-badás, B. Alonso, R. Barrio.
Tratamiento con insulina lispro en adolescentes y jóvenes con diabetes tipo 1.
An Esp Pediatr, 52 (2000), pp. 334-338
[8.]
R. Barrio.
Utilización de la insulina lispro en situaciones especiales. II. Niños y adolescentes.
Endocrinología y Nutrición, 48 (2001), pp. 44-47
[9.]
R.L. Brunelle, J. Llewelyn, J.r. Anderson JH, E.A.M. Gale, V.A. Koivisto.
Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes.
Diabetes Care, 21 (1998), pp. 1726-1731
[10.]
D. Iafusco, E. Angius, F. Prisco.
Early preprandial hypoglucemia after administration of insulin Lispro.
Diabetes Care, 21 (1998), pp. 1777-1778
[11.]
K.S. Rutledge, H.P. Chase, G.J. Klingensmith, P.A. Walravens, R.H. Slover, S.K. Garg.
Effectiveness of postprandial humalog in toddlers with diabetes.
Pediatrics, 6 (1997), pp. 968-972
[12.]
G. Schernthaner, W. Wein, K. Sandholzer, S. Equiluz-bruck, P.C. Bates, M.A. Birkett.
Postprandial insulin lispro.
Diabetes Care, 4 (1998), pp. 570-573
[13.]
P. Ebeling, P.A. Jansson, U. Smith, C. Lalli, G.B. Bolli, V.A. Koivisto.
Strategies toward improved control during insulin lispro therapy in IDDM: importance of basal insulin.
Diabetes Care, 20 (1997), pp. 1287-1289
[14.]
T.L. Levien, D.E. Baker, J.R. White, R.K. Campbell.
Insulin glargine. A new basal insulin.
Ann Pharmacother, 36 (2002), pp. 1019-1027
[15.]
P.h.D. Home, S.G. Ashwell.
An overview of insulin glargine.
Diabetes Metab Res Rev, 18 (2002), pp. S57-S63
[16.]
E. Schober, E. Schoenle, J. Van Dick.
Wernicke-paten K and the Pediatric Study Group of Insulin Glargine Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus.
J Pediatr Endocrinol Metab, 15 (2002), pp. 369-376
[17.]
R. Barrio, J. Argente, M.T. Muñoz.
Diabetes mellitus tipo 1. Tratamiento. en: Tratado de endocrinología pediátrica y de la adolescencia, 2.a ed, pp. 1237-1266
[18.]
K. McAssey, K. Perlman, Daneman.
Insulin therapy in children and adolescents with type 1 diabetes.
Diabetes Nutr Metab, 12 (1999), pp. 86-95
[19.]
D. Becker.
Individualized insulin therapy in children and adolescents with type 1 diabetes.
Acta Paediatr Suppl, 425 (1998), pp. 20-24
[20.]
A.K. Maniatis, G.J. Klingensmith, R.H. Slover, C.J. Mowry, H.P. Chase.
Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care.
Pediatrics, 107 (2001), pp. 351-356
[21.]
E.A. Boland, M. Grey, A. Oesterle, L. Fredickson, W.V. Tamborlanes.
Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes.
Diabetes Care, 22 (1999), pp. 1779-1784
[22.]
F.R. Kaufman, M. Halvorson, C.h. Kim, P. Pitukcheewanont.
Use of insulin pump therapy at night-time only for children 7-10 years of age with type 1 diabetes.
Diabetes Care, 23 (1999), pp. 579-582
[23.]
S.C. Conrad, M.T. McGrath, S.E. Gitelman.
Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus.
J Pediatr, 140 (2002), pp. 235-240
[24.]
B.W. Bode, W.V. Tamborlane, P.C. Davidson.
Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents and children with diabetes.
Postgraduate Medicine, 111 (2002), pp. 69-77
[25.]
R. Renner, A. Pfutzner, M. Trautmann, O. Harzer, K. Sauter, R. Landgraf.
Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicentral trial. The German Humalog-CSII Study Group.
Diabetes Care, 22 (1999), pp. 784-788
[26.]
R. Barrio, M. Muñoz, J. Argente.
Tratado de Nutrición Pediátrica, pp. 571-582
[27.]
American Academy of Pediatrics.
Committee on Nutrition. Towards a prudent diet for children.
Pediatrics, 71 (1983), pp. 78-80
[28.]
N.H. Herbold, S.E. Frates.
Update of nutrition guidelines for the teen: trends and concerns.
Curr Opin Pediatr, 12 (2000), pp. 303-309
[29.]
American Diabetes Association.
evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.
Diabetes Care, 25 (2002), pp. S50-S60
[30.]
A.L. Kinmonth, G. Magrath, J.P.D. Reckless.
Dietary recommendations for children and adolescents with diabetes mellitus. BDA Report.
Diabetic Med, 6 (1989), pp. 537-549
[31.]
G. Riccardi, A.A. Rivellese.
Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients.
Diabetes Care, 14 (1991), pp. 1115-1125
[32.]
A.J. Vinik, J.D.A. Jenkins.
Dietary fiber in management of diabetes.
Diabetes Care, 11 (1988), pp. 160-173
[33.]
J.L. Chiasson.
Glycemic index of foods and glycemic control in type 1 diabetes.
Curr Opin Endocrinol Diabetes, 7 (2000), pp. 25-30
[34.]
E. Loghmani, K. Rickard, L. Washburne, J. Vandagriff, N. Fineberg, M. Golden.
Glycemic response to sucrose-containing mixed meals in diets of children with insulin-dependent diabetes mellitus.
J Pediatr, 119 (1991), pp. 531-537
[35.]
K.A. Rickard, E.S. Loghmani, J.L. Cleveland, N.S. Fineberg, G.R. Freidenberg.
Lower glycemic response to sucrose in diets of children with type1 diabetes.
J Pediatr, 133 (1998), pp. 429-434
[36.]
R.H.W. Rayner.
Diet for diabetic children a change in emphasis.
Arch Dis Child, 57 (1982), pp. 487-489
[37.]
S.M. Grundy, L. Florentin, D. Nix, F. Whelan.
Comparison of monounsaturated fatty acids and carbohydrates for reducing raised levels of plasma cholesterol in man.
Am J Clin Nutr, 47 (1988), pp. 965-969
[38.]
R.J. Nicolosi, A.F. Stucchi, M. Kowwala, L.K. Hennessy, D.M. Hegsted, E.S. Scheefer.
Effect of dietary fat saturation and cholesterol on LDL composition and metabolism.
Arterioesclerosis., 10 (1990), pp. 119-128
[39.]
M.J. Wiseman, R. Dodds, J. Bending, G.G. Vibern.
Dietary protein and diabetic kidney.
Diabetic Med, 4 (1987), pp. 144-146
[40.]
A.M. Bertorelli, J.V. Czarnowski-Hill.
Review of present and future use of non nutritive sweeteners.
Diabetes Educ, 16 (1990), pp. 415-420
[41.]
American Diabetes Association.
Use of noncaloric sweeteness.
Diabetes Care, 13 (1990), pp. 26-27
[42.]
American Diabetes Association.
Diabetes mellitus and exercise.
Diabetecare, Suppl 1 (2002), pp. S64-S68
[43.]
D.H. Wasserman, B. Zinman.
Exercise in individuals with IDDM (Technical Review).
Diabetes Care, 17 (1994), pp. 924-937
[44.]
B.N. Campaigne, K.W. Landt, M. Mellies, F.W. James, C.J. Glueck, M.A. Sperling.
The effects of physical training on blood lipid profiles in adolescents with insulin-dependent diabetes mellitus.
The Physician and Sports Medicine, 13 (1985), pp. 83-89
[45.]
P.E. Mosher, M.S. Nash, A.C. Perry, A.R. LaPerriere, R.B. Goldberg.
Aerobic circuit exercise training: effect on adolescents with well-controlled insulin-dependent.
Arch of Phys Med Rehabil, 79 (1998), pp. 652-657
[46.]
S. Arslanian, P.A. Nixon, D. Becker, A.L. Drash.
Impact of physical fitness and glycaemic control on in vivo insulin action in adolescents with IDDM.
Diabetes Care, 13 (1990), pp. 9-15
[47.]
Grupo de Trabajo sobre Nutrición de la Sociedad Española de Diabetes Niveles de actividad física habitual, control glucémico y perfil de los factores de riesgo cardiovascular.
An Med Inter, 15 (1998), pp. 294-297
[48.]
A.M. Nugent, I.C. Steele, F. Al-Modaris, S. Vallely, A. Moore, N. Campbell, et al.
Exercise response in patients with IDDM Diabetes Care, 20 (1997), pp. 1814-1821
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados